Search results for "SURVIVORS"

showing 10 items of 176 documents

Prevalence of erectile dysfunction in male survivors of cancer: a systematic review and meta-analysis of cross-sectional studies.

2021

BackgroundPrevalence of erectile dysfunction (ED) in male survivors of cancer across cancer types has not been systematically analysed.AimTo estimate the prevalence of ED in all types of cancer and identify characteristics associated with ED in survivors of cancer.Design and settingSystematic review and meta-analysis (MA) of cross-sectional studies.MethodMEDLINE, CINAHL, PsycINFO, and EMBASE were searched, targeting reports published from inception to 1 February 2020. All retrospective or prospective studies reporting prevalence of ED in male patients with cancer and using a validated tool for detection of ED were included. A random-effects MA model was used to pool prevalence of ED as abso…

Malemedicine.medical_specialtyerectile dysfunctionCross-sectional studyprevalence030232 urology & nephrologyMEDLINECINAHLmeta-analysi03 medical and health sciences0302 clinical medicinesystematic reviewErectile dysfunction; Male cancer; Meta-analysis; Prevalence; Systematic reviewNeoplasmsInternal medicineHumanscancerMedicineProspective StudiesSurvivorsProspective cohort studyRetrospective Studiesbusiness.industryResearchCancermale cancermedicine.diseaseConfidence intervalmeta-analysisCross-Sectional StudiesErectile dysfunction030220 oncology & carcinogenesisMeta-analysisa systematic review and meta-analysis of cross-sectional studies.- The British journal of general practice : the journal of the Royal College of General Practitioners cilt.71 2021 [Pizzol D. Xiao T. Smith L. Sánchez G. F. L. Garolla A. Parris C. Barnett Y. Ilie P. C. Soysal P. Shin J. I. et al. -Prevalence of erectile dysfunction in male survivors of cancer]systematic review.Family Practicebusiness
researchProduct

Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy.

2009

Abstract Background After long term disease free follow up (FUp) patients reconsider quality of life (QOL) outcomes. Aim of this study is assess QoL in prostate cancer patients who are disease-free at least 5 years after radical prostatectomy (RP). Methods 367 patients treated with RP for clinically localized pCa, without biochemical failure (PSA ≤ 0.2 ng/mL) at the follow up ≥ 5 years were recruited. Urinary (UF) and Sexual Function (SF), Urinary (UB) and Sexual Bother (SB) were assessed by using UCLA-PCI questionnaire. UF, UB, SF and SB were analyzed according to: treatment timing (age at time of RP, FUp duration, age at time of FUp), tumor characteristics (preoperative PSA, TNM stage, pa…

Malemedicine.medical_specialtymedia_common.quotation_subjectUrinary systemmedicine.medical_treatmentSexual BehaviorUrologyUrinationUrinary incontinencelcsh:Computer applications to medicine. Medical informaticsUrinationProstate cancerQuality of lifeMedicineHumansSurvivorsmedia_commonAgedAged 80 and overProstatectomybusiness.industryProstatectomyResearchPublic Health Environmental and Occupational HealthProstatic NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseErectile dysfunctionProstatic NeoplasmQuality of Lifelcsh:R858-859.7Survivormedicine.symptomSexual functionbusinessHumanHealth and quality of life outcomes
researchProduct

Emotional and psychopathological disorders in laryngectomized oncological patients.

2015

It is unknown if patients who suffer from laryngeal cancer and undergo total laryngectomy experience as much emotional shock and psychological distress as patients with cancers in other locations do. The aim of the study was to identify the incidence of emotional and psychological disorders in laryngectomized patients and describe their symptomatological nuances.A descriptive cross-sectional study of emotional and psychopathological response of 100 cancer patients undergoing total laryngectomy was performed. The patients were evaluated immediately after surgery (n=35), when initiating communicative rehabilitation (n=23) and 5 years after diagnosis (n=42), versus a control of 55 healthy subj…

Malemedicine.medical_specialtymedicine.medical_treatmentEmotionsLaryngectomyAnxietyHospital Anxiety and Depression ScaleSeverity of Illness IndexStress Disorders Post-TraumaticPostoperative ComplicationsAdaptation PsychologicalInterview PsychologicalmedicineHumansSurvivorsLaryngeal NeoplasmsDepression (differential diagnoses)AgedRehabilitationbusiness.industryDepressionIncidence (epidemiology)General MedicineMiddle AgedLaryngectomyDistressCross-Sectional StudiesPhysical therapyAnxietymedicine.symptombusinessArousalAttitude to HealthClinical psychologyPsychopathologyActa otorrinolaringologica espanola
researchProduct

Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke

2016

Background and Purpose— We compared outcome and complications in patients with stroke treated with intravenous thrombolysis (IVT) who could not live alone without help of another person before stroke (dependent patients) versus independent ones. Methods— In a multicenter IVT-register–based cohort study, we compared previously dependent (prestroke modified Rankin Scale score, 3–5) versus independent (prestroke modified Rankin Scale score, 0–2) patients. Outcome measures were poor 3-month outcome (not reaching at least prestroke modified Rankin Scale [dependent patients]; modified Rankin Scale score of 3–6 [independent patients]), death, and symptomatic intracranial hemorrhage. Unadjusted an…

Malemedicine.medical_treatment030204 cardiovascular system & hematologylaw.inventionCohort Studies0302 clinical medicineRandomized controlled triallawModified Rankin ScaleActivities of Daily Living80 and overThrombolytic TherapyRegistriesStrokeriskAged 80 and overpreexisting disabilityMedicine (all)survivorsThrombolysisMiddle Aged3. Good healthStrokeTreatment OutcomeInfusions intravenous; Intracranial hemorrhages; Outcome assessment (health care); Stroke; Survivors; Administration Intravenous; Aged; Aged 80 and over; Cohort Studies; Female; Humans; Logistic Models; Male; Middle Aged; Stroke; Treatment Outcome; Activities of Daily Living; Independent Living; Registries; Thrombolytic Therapy; Medicine (all); Neurology (clinical); Cardiology and Cardiovascular Medicine; Advanced and Specialized Nursingcontrolled-trialAdministration[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Administration IntravenousFemaleIndependent Livingacute ischemic-strokehemorrhageCardiology and Cardiovascular MedicineCohort studymedicine.medical_specialtyintracranial hemorrhagesstatinsscale03 medical and health sciencesInternal medicinemedicineHumansDementiaAgedoutcome assessment (health care)Advanced and Specialized Nursingreliabilitybusiness.industryOdds ratiomedicine.diseaseConfidence intervalinfusionsSurgeryLogistic Models[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]intravenousiv thrombolysisNeurology (clinical)business030217 neurology & neurosurgeryStroke
researchProduct

Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (…

2014

Percutaneous coronary intervention (PCI) with drug-eluting stents is an accepted alternative to surgery for the treatment of unprotected left main coronary artery (ULMCA) disease, but the long-term outcome in elderly patients is unclear. Aim of our study was to compare the clinical outcomes of octogenarians with ULMCA disease treated either with PCI with drug-eluting stents or coronary artery bypass grafting (CABG). The primary study end point was the composite of death, cerebrovascular accident, and myocardial infarction at follow-up. A total of 304 consecutive patients with ULMCA stenosis treated with PCI or CABG and aged 80 years were selected and analyzed in a large multinational regist…

Malemedicine.medical_treatmentMedizinCoronaryKaplan-Meier EstimateCoronary AngiographyCohort StudiesPostoperative Complications80 and overMyocardial infarctionHospital MortalityRegistriesSurvivorsAngioplasty Balloon CoronaryCoronary Artery BypassAged 80 and overEjection fractionHazard ratioAge FactorsAge Factors; Aged 80 and over; Angioplasty Balloon Coronary; Cohort Studies; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Coronary Vessels; Female; Geriatric Assessment; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Percutaneous Coronary Intervention; Postoperative Complications; Prognosis; Propensity Score; Registries; Retrospective Studies; Risk Assessment; Survival Analysis; Survivors; Treatment Outcome; Drug-Eluting Stents; Cardiology and Cardiovascular MedicineDrug-Eluting StentsPrognosisCoronary Vesselssurgical procedures operativeTreatment OutcomeDrug-eluting stentCardiologyFemaleCardiology and Cardiovascular Medicinemedicine.medical_specialtyRevascularizationRisk AssessmentPercutaneous Coronary InterventionInternal medicineAngioplastymedicineHumanscardiovascular diseasesPropensity ScoreGeriatric AssessmentAgedRetrospective Studiesbusiness.industryAngioplastyCoronary StenosisPercutaneous coronary interventionmedicine.diseaseSurvival AnalysisSurgeryConventional PCIbusinessBalloon
researchProduct

The decision-making process for breast reconstruction after cancer surgery: Representations of heterosexual couples in long-standing relationships

2017

Objectives Most people deal with intrusive life events such as cancer and the care trajectory together with their intimate partners. To our knowledge, no research has studied the involvement of the partner in the decision-making process regarding breast reconstruction (BR) after cancer. This study aimed to gain a better understanding of the couples’ decision-making process for BR in the cancer context and particularly to investigate the partners’ involvement in this process. Method Eighteen participants (nine women who underwent a mastectomy following a first breast cancer and their intimate partners) took part in this study. We conducted semidirective interviews, and a general inductive ap…

Mammaplastymedicine.medical_treatment[SHS.PSY]Humanities and Social Sciences/Psychology[ SDV.CAN ] Life Sciences [q-bio]/CancerDevelopmental psychology0302 clinical medicine5. Gender equalityProspective StudiesSurvivors030212 general & internal medicineDecision-makingFunction (engineering)MastectomyApplied Psychologymedia_commoncouplesFamily CharacteristicsGeneral MedicineMiddle AgedEuropeSexual PartnersImpact030220 oncology & carcinogenesisoncologyMammaplastyFemalePsychologyBreast reconstructionSocial psychologyAdultreconstructionmedia_common.quotation_subjectDecision MakingBreast Neoplasms[SDV.CAN]Life Sciences [q-bio]/CancerContext (language use)Time[ SHS.PSY ] Humanities and Social Sciences/Psychology03 medical and health sciencesBreast cancermedicineHumanscancerWomenHeterosexualitySpousesAgeddecision-making processStressormedicine.diseaseAdjustmentHeterosexualityBody-imageBritish Journal of Health Psychology
researchProduct

The re-emergence of memory recovery: return of seduction theory and birth of survivorship

2005

This paper comprises an analysis of an aspect of the history of psychiatric/psychological knowledge. The case in point is the transience of the notion of memory recovery in the context of childhood sexual abuse. By transience is meant that the concept of memory recovery apparently vanished and re-emerged despite the fact that its source, childhood sexual abuse, did not disappear. Such abuse is a fairly common phenomenon worldwide, whereas memory recovery seems to be temporally and locally limited. Is it possible to say that psychiatric/psychological knowledge of memory recovery is also context-dependent and culture-bound? If so, what would this mean in relation to the applicability of this…

Memory recoveryHistoryHistory and Philosophy of SciencePoint (typography)Survivorship curveContext (language use)PsychologyDevelopmental psychologyHistory of psychiatryHistory of the Human Sciences
researchProduct

Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort

2022

Background: Evidence about late effects in adolescent and young adult (AYA) cancer survivors is scarce. This study assessed the risk of subsequent malignant neoplasms (SMNs) to identify the most common SMNs to be considered in follow-up care. Methods: Population-based cancer registries retrospectively identified first primary tumors (between 1976 and 2013) and SMNs in AYAs (15-39 years old at their cancer diagnosis). AYA cancer survivors were those alive at least 5 years after their first cancer diagnosis. The excess risk of SMNs was measured as standardized incidence ratios (SIRs) and absolute excess risk together with the cumulative incidence of SMNs. Results: The cohort included 67,692 A…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyAdolescentColorectal cancercancer survivorPopulationBreast NeoplasmsSettore MED/42 - Igiene Generale E ApplicataProstate cancerBreast cancerRisk FactorsInternal medicineNeoplasmsfollow-upMedicineHumanscancer survivorsCumulative incidenceadolescentseducationLung cancerRetrospective Studieseducation.field_of_studyBladder cancerbusiness.industryIncidenceCancerregistriesNeoplasms Second Primarymedicine.diseasehumanitiesregistrieOncologyadolescents cancer survivors follow-up registries young adultyoung adultFemalebusiness
researchProduct

The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of …

2008

The aim of this study was to provide further quantitative data on the risk of second nonmelanoma cancers in patients with cutaneous malignant melanoma (CMM). A cohort of 14 560 population-based patients from the Italian Network of Cancer Registries incident during 1985-2002 were included and followed up for further incident cases and vital status. Standardized incidence ratios (SIR) were used to compare the number of observed second cancers with expected cancers. In a total of 69 581 person-years, 1020 second cancers were registered, of which 804.6 were expected (SIR=1.27; 95% confidence interval 1.19-1.35). The risk was similar for males and females, (SIR=1.27 and 1.26, respectively). The …

OncologyAdultMaleCancer Researchmedicine.medical_specialtySkin NeoplasmsSettore MED/06 - Oncologia MedicaPopulationDermatologyCohort StudiesRisk FactorsInternal medicineEpidemiology of cancerMedicineHumansRegistriesSurvivorseducationMelanomaAgedAged 80 and overeducation.field_of_studybusiness.industryIncidence (epidemiology)CancerNeoplasms Second PrimaryMiddle Agedmedicine.diseasehumanitiesConfidence intervalcutaneous melanomacancerOncologyItalyCohortCutaneous melanomaFemalesecond cancer - survivors - malignant melanomabusinessCohort studyFollow-Up StudiesMelanoma research
researchProduct

Cancer: New Needs, New Models. Is It Time for a Community Oncologist? Another Brick in the Wall

2021

Simple Summary Community care activity in the oncology field does not exist. This unmet need contrasts with the increasing number of patients with a previous diagnosis of cancer. Abstract Over the last few decades, thanks to early detection, effective drugs, and personalized treatments, the natural history of cancer has radically changed. Thanks to these advances, we have observed how survival of cancer patients has increased, becoming an ever more important goal in cancer care. Effective clinical governance of survivorship care is essential to ensure a successful transition between active and post-treatment life, identifying optimization of healthcare outcomes and quality of life for patie…

OncologyCancer Researchmedicine.medical_specialtySettore MED/06 - Oncologia MedicaEarly detectionSettore MED/42 - Igiene Generale E Applicataclinical governance03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Internal medicineSurvivorship curveIntervention (counseling)Health caremedicine030212 general & internal medicineRC254-282Clinical governancebusiness.industryCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasecommunity oncologyNatural historycancer survivorshipOncology030220 oncology & carcinogenesisPerspectivebusinessPsychologyCancers
researchProduct